Pharmacology

Action Mechanism of Action Reference
AGONIST Erythropoietin receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
13.26
Cardiac disorders
12.55
Nervous system disorders
10.54
Respiratory, thoracic and mediastinal disorders
10.45
Skin and subcutaneous tissue disorders
8.43
Vascular disorders
8.34
Gastrointestinal disorders
7.64
Immune system disorders
7.11
Investigations
6.5
Musculoskeletal and connective tissue disorders
4.48
Psychiatric disorders
2.55

Cross References

Resources Reference
ChEMBL CHEMBL1963684
FDA SRS 44STI720CW